Christophe Deroose

Learn More
In emission tomography, image reconstruction and therefore also tracer development and diagnosis may benefit from the use of anatomical side information obtained with other imaging modalities in the same subject, as it helps to correct for the partial volume effect. One way to implement this, is to use the anatomical image for defining the a priori(More)
For positron emission tomography (PET) imaging, different reconstruction methods can be applied, including maximum likelihood (ML ) and maximum a posteriori (MAP) reconstruction. Postsmoothed ML images have approximately position and object independent spatial resolution, which is advantageous for (semi-) quantitative analysis. However, the complex object(More)
UNLABELLED Mitochondrial membrane potential (DeltaPsim)-dependent enhanced uptake of phosphonium salts, including (3)H-tetraphenylphosphonium ((3)H-TPP), in tumor cells, suggests the potential use of phosphonium salts as tracers for tumor imaging. In this study, we characterize the tumor accumulation of (3)H-TPP and compare it with (18)F-FDG in cell culture(More)
Early therapy response prediction, employing biomarkers such as 18 F-fluorodeoxyglucose (FDG) followed with positron emission to-mography (PET), is an actively researched topic. Traditionally, only the first order intensity based feature estimates are used for the response evaluations. In this work, we focus on the predictive power of lesion texture along(More)
18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has become the de facto standard for current clinical therapy follow up evaluations. In pursuit of robust biomarkers for predicting early therapy response, an efficient marker quantification procedure is certainly a necessity. Among various PET derived markers, the clinical investigations(More)
  • 1